Sarepta Therapeutics (SRPT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
74.10 +0.65 (+0.88%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 73.82 -0.28 (-0.38%) 18:40 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | SRPT | ROIV | RVMD | ||
| Company | Sarepta Therapeutics | Roivant Sciences Ltd | Revolution Medicines Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 73.32 | 10.89 | 38.15 | ||
| High | 75.50 | 10.98 | 38.81 | ||
| Low | 73.05 | 10.63 | 37.61 | ||
| Last | 74.10 | 10.79 | 38.11 | ||
| Change | +0.65 | -0.18 | -0.38 | ||
| % Change | +0.88% | -1.64% | -0.99% | ||
| Volume | 2,592,700 | 15,739,801 | 2,499,600 | ||
| 20-Day Average Volume | 2,145,285 | 6,808,805 | 1,460,040 | ||
| Previous Close | 73.45 | 10.97 | 38.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 97.38 | 10.61 | 39.15 | ||
| 20-Day Raw Stochastic | 2.88% | 57.04% | 32.57% | ||
| 20-Day Relative Strength | 29.59% | 49.95% | 41.83% | ||
| Weighted Alpha | -52.79 | +1.22 | +5.94 | ||
| Today's Opinion | 100% Sell | 48% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 48% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -23.76% since 03/14/25 | +1.22% since 03/14/25 | -2.58% since 03/14/25 | ||
| Low | 73.05 on 03/21/25 | 10.48 on 03/17/25 | 37.61 on 03/21/25 | ||
| High | 103.32 on 03/17/25 | 11.41 on 03/19/25 | 39.63 on 03/17/25 | ||
| 1-Month | |||||
| %Chg | -30.28% since 02/21/25 | +1.03% since 02/21/25 | -7.81% since 02/21/25 | ||
| Low | 73.05 on 03/21/25 | 9.96 on 03/04/25 | 36.13 on 03/10/25 | ||
| High | 109.55 on 02/26/25 | 11.41 on 03/19/25 | 42.22 on 02/25/25 | ||
| 3-Month | |||||
| %Chg | -37.72% since 12/20/24 | -6.74% since 12/20/24 | -13.50% since 12/20/24 | ||
| Low | 73.05 on 03/21/25 | 9.96 on 03/04/25 | 36.13 on 03/10/25 | ||
| High | 129.84 on 01/07/25 | 12.20 on 01/02/25 | 45.64 on 12/26/24 | ||
| 6-Month | |||||
| %Chg | -41.75% since 09/20/24 | -9.86% since 09/20/24 | -16.09% since 09/20/24 | ||
| Low | 73.05 on 03/21/25 | 9.96 on 03/04/25 | 36.13 on 03/10/25 | ||
| High | 138.81 on 11/29/24 | 12.94 on 11/25/24 | 62.40 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,190,071 | 7,699,194 | 7,085,145 | ||
| Shares Outstanding, K | 97,032 | 713,549 | 185,913 | ||
| Annual Sales | 1,901,980,000 | 124,800,000 | 0 | ||
| Annual Net Income | 235,240,000 | 4,348,930,000 | -600,090,000 | ||
| Last Quarter Sales | 658,410,000 | 9,020,000 | 0 | ||
| Last Quarter Net Income | 159,050,000 | 169,380,000 | -194,570,000 | ||
| 60-Month Beta | 0.79 | 1.26 | 1.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.50 on 02/26/25 | -0.13 on 02/10/25 | -1.12 on 02/26/25 | ||
| Latest Earnings Date | 05/07/25 | 02/10/25 | 05/14/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 33.54 | 0.00 | 0.00 | ||